SHL Telemedicine to Delist ADRs from Nasdaq to Cut Costs

Shl Telemedicine ( (CH:SHLTN) ) has shared an update.

SHL Telemedicine Ltd. has announced its decision to voluntarily delist its American Depositary Receipts (ADRs) from the Nasdaq Capital Market and terminate its U.S. ADR program and SEC reporting obligations, while maintaining its listing on the SIX Swiss Exchange. This strategic move is driven by the current global economic climate and the company’s aim to reduce costs, as it believes the SIX Swiss Exchange provides sufficient liquidity for its investors. The delisting and termination of the ADR program are expected to streamline operations and focus resources, while the company continues to grow its U.S. business.

More about Shl Telemedicine

SHL Telemedicine is a company focused on developing and marketing personal telemedicine systems and providing medical call center services, primarily targeting cardiovascular and related diseases. It offers these services and devices to subscribers through telephonic and Internet communication technology, and is listed on the SIX Swiss Exchange.

Current Market Cap: CHF145.3M

For an in-depth examination of SHLTN stock, go to TipRanks’ Stock Analysis page.